Drug recall · August 6, 2025
Timolol Maleate Ophthalmic Solution USP recall
Why: Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.
- Lots / codes
Lot#: 083L061, Exp.: 11/2025.
- Quantity
- 154,176 bottles
- Company
- FDC Limited, Aurangabad, Maharashtra State
- Distribution
- U.S Nationwide.
- Initiated
- July 5, 2025 · Voluntary: Firm initiated
- Classified
- July 29, 2025
- Reported
- August 6, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.